159 related articles for article (PubMed ID: 7070886)
1. Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months.
Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD
Pediatrics; 1982 Apr; 69(4):404-8. PubMed ID: 7070886
[TBL] [Abstract][Full Text] [Related]
2. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
[TBL] [Abstract][Full Text] [Related]
3. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
4. Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines.
Bernstein DI; Zahradnik JM; DeAngelis CJ; Cherry JD
Am J Dis Child; 1982 Jun; 136(6):513-7. PubMed ID: 7046421
[TBL] [Abstract][Full Text] [Related]
5. [Comparison between killed subunit influenza vaccines and whole virion preparations: study of reactions and protective efficacy in children and adults].
Profeta ML; Bigatello A; Vacchini V; Bramati L; Ferrante P
Boll Ist Sieroter Milan; 1980 Jan; 58(6):457-74. PubMed ID: 6778485
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
King JC; Cox MM; Reisinger K; Hedrick J; Graham I; Patriarca P
Vaccine; 2009 Nov; 27(47):6589-94. PubMed ID: 19716456
[TBL] [Abstract][Full Text] [Related]
7. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.
Neuzil KM; Jackson LA; Nelson J; Klimov A; Cox N; Bridges CB; Dunn J; DeStefano F; Shay D
J Infect Dis; 2006 Oct; 194(8):1032-9. PubMed ID: 16991077
[TBL] [Abstract][Full Text] [Related]
9. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
Sugimura T; Ito Y; Tananari Y; Ozaki Y; Maeno Y; Yamaoka T; Kudo Y
Vaccine; 2008 May; 26(22):2700-5. PubMed ID: 18436353
[TBL] [Abstract][Full Text] [Related]
10. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children.
Englund JA; Walter EB; Fairchok MP; Monto AS; Neuzil KM
Pediatrics; 2005 Apr; 115(4):1039-47. PubMed ID: 15805382
[TBL] [Abstract][Full Text] [Related]
11. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults.
Warshauer DM; Minor TE; Inhorn SL; Reed CE; Dick EC
Dev Biol Stand; 1976; 33():184-90. PubMed ID: 782967
[TBL] [Abstract][Full Text] [Related]
12. [Safety and immunogenicity of split vaccines of influenza viruses].
Zhu CL; Fang HH; Zhu FC; Wang YQ; Wu XL; Xue FB; Shen YJ; Lian JZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):207-9. PubMed ID: 15640848
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials with a new influenza subunit vaccine in adults and children.
Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz AJ
Dev Biol Stand; 1977 Jun 1-3; 39():297-302. PubMed ID: 342311
[TBL] [Abstract][Full Text] [Related]
14. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma.
Zuccotti G; Amendola A; Viganò A; Pariani E; Zappa A; Pogliani L; Giacomet V; Savarino A; Podestà A; Rottoli A; Tanzi E; Zanetti A; Radaelli G
Vaccine; 2007 Sep; 25(37-38):6692-8. PubMed ID: 17697730
[TBL] [Abstract][Full Text] [Related]
15. Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study.
Stowe J; Andrews N; Bryan P; Seabroke S; Miller E
Vaccine; 2011 Nov; 29(51):9467-72. PubMed ID: 22019757
[TBL] [Abstract][Full Text] [Related]
16. Trivalent inactivated influenza virus vaccine given to two-month-old children: an off-season pilot study.
Walter EB; Englund JA; Blatter M; Nyberg J; Ruben FL; Decker MD;
Pediatr Infect Dis J; 2009 Dec; 28(12):1099-104. PubMed ID: 19935270
[TBL] [Abstract][Full Text] [Related]
17. [Safety of an influenza-split-vaccine in children].
Schmitt-Grohé S; Banzhoff A; Klaassen B; Zielen S
Klin Padiatr; 2001; 213(6):338-42. PubMed ID: 11713714
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G
Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951
[TBL] [Abstract][Full Text] [Related]
19. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
20. Immune response after influenza vaccination in children with cancer.
Matsuzaki A; Suminoe A; Koga Y; Kinukawa N; Kusuhara K; Hara T
Pediatr Blood Cancer; 2005 Nov; 45(6):831-7. PubMed ID: 16007602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
